Best blood thinner plan for atrial fibrillation after stent
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares different blood-thinner (“antithrombotic”) strategies in people with atrial fibrillation or flutter who recently had a stent placed (PCI). It aims to find a plan that lowers clot risk while keeping bleeding risk as low as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You recently had a stent procedure (PCI), either urgent or planned
- You have atrial fibrillation/flutter that is either known already or started within 72 hours after the heart event
- You have a long-term reason to take oral anticoagulation (a long-term blood thinner) for at least 1 year
- You do not have conditions that make blood thinners (edoxaban, aspirin, or P2Y12 medicines) unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a rhythm-guided approach to using blood thinners (antithrombotics) is safe and effective for people who have had both a heart stent and a successful ablation for atrial fibrillation. It may help you avoid unnecessary medication while preventing strokes and bleeds.
This study tests whether taking dabigatran (a blood thinner) combined with ticagrelor (a blood clot preventer) is safe and effective for patients with irregular heart rhythm (atrial fibrillation) who recently had a heart attack and received a stent. The goal is to prevent future blood clots while minimizing bleeding risks.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
This Phase 4 study tests whether using a reduced blood-thinner (antithrombotic) strategy after a heart attack can lower bleeding without losing heart protection. It is mainly for people considered high risk for bleeding after getting a stent.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.